Independent Advisor Alliance’s BioNTech BNTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
Sell
-1,343
Closed -$229K 633
2022
Q1
$229K Sell
1,343
-302
-18% -$50.7K 0.01% 575
2021
Q4
$424K Sell
1,645
-40
-2% -$11K 0.02% 431
2021
Q3
$460K Sell
1,685
-15
-0.9% -$4.77K 0.03% 404
2021
Q2
$381K Buy
+1,700
New +$321K 0.02% 450
2021
Q1
Sell
-18,194
Closed -$1.48M 597
2020
Q4
$1.48M Buy
+18,194
New +$1.79M 0.1% 160

Other funds holding BNTX

Independent Advisor Alliance's BNTX Position: Q2 2022 in Review

Independent Advisor Alliance sold out of BioNTech (BNTX) in Q2 2022, closing a stake of 1,343 shares — an estimated $229K sold.

Independent Advisor Alliance first reported a position in BNTX in Q4 2020 and held it in 5 quarters. The position peaked at $1.48M in Q4 2020. 293 funds tracked by Wall St. Rank hold BNTX as of Q2 2022.

  • Independent Advisor Alliance reported no remaining BioNTech position as of Q2 2022 after selling out during the quarter.
  • Independent Advisor Alliance sold 1,343 BioNTech shares in Q2 2022, an estimated $229K.
  • Independent Advisor Alliance first reported a position in BioNTech in Q4 2020 and held it in 5 quarters.
  • Independent Advisor Alliance's BioNTech position peaked at $1.48M in Q4 2020.
  • 293 funds tracked by Wall St. Rank held BioNTech as of Q2 2022.

Based on Independent Advisor Alliance's 13F filing for Q2 2022, filed 4 Aug 2022.